Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.800
-0.040 (-2.17%)
At close: Oct 22, 2024, 4:00 PM
1.805
+0.005 (0.28%)
Pre-market: Oct 23, 2024, 6:59 AM EDT
PACB Revenue
Pacific Biosciences of California had revenue of $36.01M in the quarter ending June 30, 2024, a decrease of -24.30%. This brings the company's revenue in the last twelve months to $188.87M, up 29.24% year-over-year. In the year 2023, Pacific Biosciences of California had annual revenue of $200.52M with 56.29% growth.
Revenue (ttm)
$188.87M
Revenue Growth
+29.24%
P/S Ratio
2.54
Revenue / Employee
$237,275
Employees
796
Market Cap
490.55M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 200.52M | 72.22M | 56.29% |
Dec 31, 2022 | 128.30M | -2.21M | -1.69% |
Dec 31, 2021 | 130.51M | 51.62M | 65.43% |
Dec 31, 2020 | 78.89M | -12.00M | -13.20% |
Dec 31, 2019 | 90.89M | 12.27M | 15.60% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Auna S.A. | 1.10B |
Emergent BioSolutions | 1.10B |
Varex Imaging | 832.70M |
Health Catalyst | 299.48M |
Ginkgo Bioworks Holdings | 184.34M |
Talkspace | 172.54M |
Verve Therapeutics | 20.65M |
PureTech Health | 468.00K |
PACB News
- 20 hours ago - The Schall Law Firm Encourages Investor Participation In An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud - Accesswire
- 22 hours ago - PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program - GlobeNewsWire
- 1 day ago - Pacific Biosciences of California, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
- 2 days ago - The Schall Law Firm Encourages Investor Participation In An Inquiry Into Pacific Biosciences of California Inc For Possible Securities Fraud - Accesswire
- 4 days ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Pacific Biosciences of California Inc For Possible Securities Fraud - Accesswire
- 5 days ago - Pacific Biosciences of California, Inc. Is Being Investigated For Securities Related Infractions And The Schall Law Firm Urges Impacted Shareholders To Reach Out - Accesswire
- 6 days ago - Investors Are Encouraged To Join The Schall Law Firm In An Inquiry Into Pacific Biosciences of California Inc For Securities Fraud - Accesswire
- 7 days ago - Pacific Biosciences of California, Inc. Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Shareholders To Reach Out - Accesswire